Edesa Biotech's EBIT per Share for the
three
months ended in Mar. 2024 was $-0.60.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.44.
During the past 3 years, the average EBIT per Share Growth Rate was -59.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 9.90% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 33.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Edesa Biotech's EBIT per Share or its related term are showing as below:
EDSA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -77.5 Med: 14.05 Max: 71.1
Current: -59.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Edesa Biotech was 71.10% per year. The lowest was -77.50% per year. And the median was 14.05% per year.
EDSA's 3-Year EBIT Growth Rate is ranked worse than 91.95% of 1305
companies
in the Biotechnology industry
Industry Median: 3.6
vs EDSA: -59.70
Edesa Biotech's EBIT for the
three
months ended in Mar. 2024 was $-1.92 Mil.
Edesa Biotech EBIT per Share Historical Data
The historical data trend for Edesa Biotech's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edesa Biotech (NAS:EDSA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Edesa Biotech EBIT per Share Related Terms
Thank you for viewing the detailed overview of Edesa Biotech's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Edesa Biotech (Edesa Biotech) Business Description
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EDSA has been successfully added to your 